Ardent Health Partners (NYSE:ARDT) Receives “Overweight” Rating from Stephens

Stephens reiterated their overweight rating on shares of Ardent Health Partners (NYSE:ARDT) in a research report released on Tuesday,Benzinga reports. Stephens currently has a $21.00 price target on the stock.

A number of other analysts have also commented on ARDT. Royal Bank of Canada reissued an “outperform” rating and issued a $21.00 target price on shares of Ardent Health Partners in a report on Thursday, May 15th. Mizuho reduced their target price on Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating for the company in a report on Wednesday, April 9th. Guggenheim lifted their target price on Ardent Health Partners from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Friday, May 9th. Finally, Morgan Stanley reduced their target price on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a report on Tuesday, January 21st. Two equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, Ardent Health Partners presently has a consensus rating of “Buy” and a consensus price target of $20.67.

Ardent Health Partners Stock Down 0.3%

ARDT stock opened at $15.10 on Tuesday. Ardent Health Partners has a twelve month low of $11.31 and a twelve month high of $20.72. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. The firm has a market cap of $2.16 billion and a PE ratio of 9.26. The business has a 50 day moving average of $13.20 and a 200 day moving average of $14.80.

Ardent Health Partners (NYSE:ARDT) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.08. The company had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.50 billion. On average, research analysts forecast that Ardent Health Partners will post 1.23 EPS for the current fiscal year.

Institutional Trading of Ardent Health Partners

Large investors have recently modified their holdings of the company. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Ardent Health Partners in the fourth quarter worth $27,000. US Bancorp DE bought a new stake in Ardent Health Partners during the fourth quarter valued at about $31,000. R Squared Ltd bought a new stake in Ardent Health Partners during the fourth quarter valued at about $37,000. Morse Asset Management Inc bought a new stake in Ardent Health Partners during the first quarter valued at about $36,000. Finally, New York State Common Retirement Fund bought a new stake in Ardent Health Partners during the fourth quarter valued at about $48,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.